Acrivon Therapeutics, Inc. (ACRV)
1.76
+0.04
(+2.33%)
USD |
NASDAQ |
Oct 15, 13:57
Acrivon Therapeutics Price : 1.76 for Oct. 15, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 14, 2026 | 1.73 | 1.81 | 1.70 | 1.72 | 215811.0 |
| Oct 13, 2026 | 1.86 | 1.872 | 1.74 | 1.75 | 477271.0 |
| Oct 12, 2026 | 1.91 | 1.929 | 1.87 | 1.90 | 140652.0 |
| Oct 09, 2026 | 1.88 | 1.955 | 1.862 | 1.91 | 192042.0 |
| Oct 08, 2026 | 1.89 | 1.905 | 1.78 | 1.87 | 419700.0 |
| Oct 07, 2026 | 1.85 | 1.913 | 1.82 | 1.88 | 283455.0 |
| Oct 06, 2026 | 2.00 | 2.07 | 1.85 | 1.86 | 158748.0 |
| Oct 05, 2026 | 1.99 | 2.035 | 1.91 | 1.98 | 402171.0 |
| Oct 02, 2026 | 2.05 | 2.06 | 1.99 | 1.99 | 205122.0 |
| Oct 01, 2026 | 2.02 | 2.12 | 2.00 | 2.01 | 316874.0 |
| Sep 30, 2026 | 2.09 | 2.16 | 2.04 | 2.05 | 176934.0 |
| Sep 29, 2026 | 2.05 | 2.12 | 2.05 | 2.08 | 132698.0 |
| Sep 28, 2026 | 2.08 | 2.12 | 2.025 | 2.06 | 231032.0 |
| Sep 25, 2026 | 2.12 | 2.13 | 2.07 | 2.10 | 181953.0 |
| Sep 24, 2026 | 2.10 | 2.15 | 2.04 | 2.12 | 317066.0 |
| Sep 23, 2026 | 2.14 | 2.17 | 2.025 | 2.06 | 435424.0 |
| Sep 22, 2026 | 2.04 | 2.24 | 2.01 | 2.15 | 572485.0 |
| Sep 21, 2026 | 1.89 | 2.025 | 1.871 | 2.01 | 333997.0 |
| Sep 18, 2026 | 1.71 | 1.895 | 1.69 | 1.85 | 478190.0 |
| Sep 17, 2026 | 1.74 | 1.77 | 1.67 | 1.70 | 463838.0 |
| Sep 16, 2026 | 1.85 | 1.90 | 1.695 | 1.70 | 765119.0 |
| Sep 15, 2026 | 1.97 | 1.975 | 1.805 | 1.83 | 304884.0 |
| Sep 14, 2026 | 1.98 | 1.99 | 1.94 | 1.96 | 208341.0 |
| Sep 11, 2026 | 2.05 | 2.06 | 1.95 | 2.00 | 461586.0 |
| Sep 10, 2026 | 2.03 | 2.06 | 1.96 | 2.04 | 323974.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.67 |
| Alnylam Pharmaceuticals, Inc. | 232.48 |
| Anika Therapeutics, Inc. | 20.77 |
| Savara, Inc. | 4.77 |
| Vericel Corp. | 41.34 |
Price Related Metrics
| Price to Book Value | 0.8702 |
| Earnings Yield | -107.1% |
| Market Cap | 75.41M |